# RF Acquisition Corp II (RFAIU) — spac/ipo [completed]
Source: SEC API (secapi.ai) · situation sit_658adf26cbe7039b1b26 · retrieved 2026-08-11T16:12:02.166Z

## Overview
RF Acquisition Corp II is a Cayman Islands-incorporated blank-check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

RF Acquisition Corp II (RFAC), a blank-check company, signed a definitive Business Combination Agreement with NYB Holdings Limited (PubCo), NYB Pte. Ltd. (Amalgamation Sub), and Nanyang Biologics Pte. Ltd. (Target) on October 2, 2025. The transaction is awaiting SEC effectiveness of the Form F-4 registration statement and Nasdaq listing approval before closing. RFAC shareholders are being asked to approve an extension of the business combination deadline from August 15, 2026 to February 15, 2027 (up to six one-month extensions at $75,000 per extension), with the extension contingent on shareholder approval of both the Extension Amendment Proposal and Trust Agreement Amendment Proposal at an Extraordinary General Meeting scheduled for August 12, 2026.

## Terms
- Counterparty: NYB Holdings Limited, NYB Pte. Ltd., and Nanyang Biologics Pte. Ltd.

## Key dates
- Record 2026-06-25 · Vote 2026-08-12 · Expiry 2027-02-15 · Completed 2024-05-21

## Timeline
- 2026-07-31 · DEF 14A (0001829126-26-008243): DEF 14A - RF Acquisition Corp II — *RF Acquisition Corp II is a Cayman Islands-incorporated blank-check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.* RF Acquisition Corp II (RFAC), a blank-check company, signed a definitive Business Combination Agreement with NYB Holdings Limited (PubCo), NYB Pte. Ltd. (Amalgamation Sub), and Nanyang Biologics Pte. Ltd. (Target) on October 2, 2025. The transaction is awaiting SEC effectiveness of the Form F-4 registration statement and Nasdaq listing approval before closing. RFAC shareholders are being asked to approve an extension of the business combination deadline from August 15, 2026 to February 15, 2027 (up to six one-month extensions at $75,000 per extension), with the extension contingent on shareholder approval of both the Extension Amendment Proposal and Trust Agreement Amendment Proposal at an Extraordinary General Meeting scheduled for August 12, 2026.
  https://www.sec.gov/Archives/edgar/data/2012807/0001829126-26-008243.txt

## Citations
- 0001829126-26-008243 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000182912626008243